PMID 23417317 Zdrada-Nowak, J., Surgiel-Gemza, A., & Szatkowska, M
Injectable healing protocol: Dose: 2-3mg daily (higher end of range) Frequency: Daily throughout healing period Duration: Until wound resolves plus 1-2 weeks Injection site: Systemic (not into wound) Topical healing protocol: Concentration: 2-4% in wound-appropriate vehicle Application: 2-3 times daily to wound margins (not directly into open wounds) Duration: Throughout healing process Note: Consult healthcare provider for significant wounds GHK-CU pairs exceptionally well with BPC-157 and TB-500 for wound healing

Approximate Reading Time: 68 Minutes Clinical Applications OcluMed may support the following conditions and symptoms: Dry Eyes Cataracts (Senile, Nuclear, Cortical) Decreased Visual Acuity Lens Opacity Glycation of the Lens (age-related protein damage) Postpone or potentially avoid cataract surgery (based on early clinical data) I was scheduled to have cataract surgery after using the drops for two months, surgery was canceled! Donald Smith, Patient results reported by OcluMed
J.LuY.WangH.et al
By wrapping the glutathione in these healthy fats, the supplement is protected from the harsh environment of the stomach
Role of brain neurotransmitters on neurotensin-induced gastric cytoprotection